Healthcare / Health Information ServicesNasdaqGS
$18.38
+0.41 (+2.28%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-38.0M · quality 42.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
27/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-5.6%
↓Gross Margin
65.7%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+42.9%
FCF CAGR
—
FCF margin
4.8%
FCF / Net income
-0.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $260.2M · net income $-12.8M · FCF $12.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $260.2M | $260.2M | $169.8M | $122.8M | $89.2M |
| Net Income | $-12.8M | $-12.8M | $-47.1M | $-67.5M | $-72.5M |
| EBITDA | $-4.8M | $-4.8M | $-37.8M | $-58.4M | $-64.0M |
| EPS | -0.35 | -0.35 | -0.85 | -1.41 | -1.52 |
| Gross Margin | 65.7% | 65.7% | 60.6% | 57.0% | 48.0% |
| Operating Margin | -4.6% | -4.6% | -25.7% | -53.8% | -81.1% |
| Net Margin | -4.9% | -4.9% | -27.8% | -55.0% | -81.3% |
| Balance Sheet | |||||
| Debt/Equity | — | — | -0.08 | 0.31 | 0.20 |
| Current Ratio | 3.92 | 3.92 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $12.4M | $12.4M | $-38.0M | $-52.7M | $-71.7M |
| Returns | |||||
| ROE | -5.6% | -5.6% | 12.3% | -68.2% | -46.6% |
| Valuation | |||||
| P/B | 2.93 | 2.93 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 53.2% | 53.2% | 38.3% | 37.7% | — |
| EPS Growth | 58.6% | 58.6% | 40.2% | 6.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-20.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.85 → -0.35
Residual
-20.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.